Clinical trial
A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
NCT00221468 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00221468 |
|---|---|
| Title | A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents |
| Official title | A Single-Blind Prospective Study of Quetiapine for the Treatment of Mood Disorders in Adolescents |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mood Disorders |
| Intervention type | Drug |
| Interventions | quetiapine |
| Enrollment | 20 |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: